Concepedia

Arlene Berman

AB

Statistics

Publications

35

Citations

3.5K

H-Index

26

Active since

1984

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

Georgetown University

National Institutes of Health Clinical Center

Arlene Berman is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

Publications per year

1984–2019

35

Publications

35

Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer

Suparna Wedam, Jennifer A. Low, Sherry X. Yang et al. · Journal of Clinical Oncology · 2006 · 524 citations · Full text

, , +14

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

Anish Thomas, Arun Rajan, Arlene Berman et al. · The Lancet Oncology · 2015 · 299 citations · Full text

, , +8

Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial

Ariel López-Chávez, Anish Thomas, Arun Rajan et al. · Journal of Clinical Oncology · 2015 · 235 citations

, , +17

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Metastatic and Locally Advanced Breast Cancer

Jennifer A. Low, Suparna Wedam, James J. Lee et al. · Journal of Clinical Oncology · 2005 · 215 citations

, , +15

Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

Giuseppe Giaccone, Arun Rajan, Arlene Berman et al. · Journal of Clinical Oncology · 2011 · 188 citations · Full text

, , +12

1–5 of 35